Figure 4
From: Screening for an ivermectin slow-release formulation suitable for malaria vector control
Modelling the potential impact of slow-release ivermectin formulations. Panel A: Expected change in vector survival in the presence of ivermectin treatment in the community. Panel B: Expected percentage change in the infectious vector density in time in the presence of different long-lasting ivermectin formulations. Panel C: Reductions in clinical incidence and entomological inoculation rate in the six months following implementation of a long-lasting ivermectin formulation.